View Author
Verstraete, M.
(Marc Verstraete)
patient trial group infarction treatment heparin therapy study alteplase infusion angiography mortality aspirin thrombolytic therapy 1 patient artery reocclusion stenosi stroke placebo hospital vessel reinfarction american alteplase /ptca trial angioplasty thrombolytic infarct-related tissue-type plasminogen activator european chest heart infarct size difference alteplase /placebo trial thrombolysi streptokinase rt-pa analysis antithrombotic antithrombotic therapy swets subscription service patency hospital discharge discharge 1 year confidence table infarct activator percutaneous transluminal grade valve recommendation result randomized plasminogen ejection fraction interval level patent lmw heparin intracoronary streptokinase tissue plasminogen activator number angiogram anticoagulation study group strategy thromboembolism acetylsalicylic acid benefit venous thromboembolism range intracoronary infarct-related vessel service prevention randomised baseline
10 Most Recent Publications
|
A European view on the north american fifth consensus on antithrombotic therapy
(Article)
Verstraete, M. Prentice, C.R.M. Samama, M. Verhaeghe, R. Simoons, M.L. |
2000-01-01
|
|
Benefit of Thrombolytic Therapy is Sustained Throughout Five Years and Is Related to TIMI Perfusion Grade 3 But Not Grade 2 Flow at Discharge
(Article)
Lenderink, T. Simoons, M.L. Es, G.A. van Verstraete, M. Arnold, A.E.R. Werf, F.J.J. van de |
1995-01-01
|
|
Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial infarction with alteplase (rt-PA)
(Article)
Simoons, M.L. Rapold, H.J. Collen, D. Verstraete, M. Arnout, J. |
1992-01-01
|
|
Recombinant tissue-type plasminogen activator and immediate angioplasty in acute myocardial infarction.
(Article)
Arnold, A.E.R. Simoons, M.L. Bono, D.P. de Tijssen, J.G.P. Serruys, P.W.J.C. Verstraete, M. Lubsen, J. Werf, F.J.J. van de |
1992-01-01
|
|
Reasons for the lack of benefit of immediate angioplasty during recombinant tissue plasminogen activator therapy for acute myocardial infarction: a regional wall motion analysis
(Article)
Serruys, P.W.J.C. Rutsch, W.R. Simoons, M.L. Bono, D.P. de Tijssen, J.G.P. Lubsen, J. Verstraete, M. Arnold, A.E.R. |
1991-01-01
|
|
Increased serum levels of fibrinogen degradation products due to treatment with recombinant tissue-type plasminogen activator for acute myocardial infarction are related to bleeding complications, but not to coronary patency
(Article)
Brower, R.W. Collen, D. Es, G.A. van Lubsen, J. Serruys, P.W.J.C. Simoons, M.L. Verstraete, M. Arnold, A.E.R. |
1989-01-01
|
|
Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty
(Article)
Simoons, M.L. Betriu, A. Willems, G.M. Bono, D.P. de Dougherty, F.C. Lambertz, H. Meier, B. Raynaud, P. Sanz, G.A. Serruys, P.W.J.C. Uebis, R. Wood, D. Col, J.J. Verstraete, M. Arnold, A.E.R. Werf, F.J.J. van de Essen, R. von Lubsen, J. Michel, P.L. Rutsch, W.R. Schmidt, W. Thery, C. Vahanian, A. |
1988-01-30
|
|
Thrombolysis with rt-PA in acute myocardial infarction: no additional benefit of immediate PTCA
(Miscellaneous)
Simoons, M.L. Betriu, A. Meier, B. Michel, P.L. Raynaud, P. Rutsch, W.R. Sanz, G.A. Schmidt, W. Serruys, P.W.J.C. Thery, C. Uebis, R. Vahanian, A. Bokslag, M. Willems, G.M. Wood, D. Verstraete, M. Arnold, A.E.R. Werf, F.J.J. van de Bono, D.P. de Brower, R.W. Col, J.J. Dougherty, F.C. Essen, R. von Lambertz, H. Lubsen, J. |
1988-01-30
|
|
Thrombolytic therapy and percutaneous coronary angioplasty
(Article)
Simoons, M.L. Verstraete, M. Wood, D. |
1988-01-01
|
|
Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: initial patency and influence of maintained infusion on reocclusion rate
(Article)
Verstraete, M. Brower, R.W. Reid, D.S. Rutsch, W.R. Schartl, M. Schofer, J. Serruys, P.W.J.C. Simoons, M.L. Uebis, R. Vahanian, A. Verheugt, F.W.A. Essen, R. von Collen, D. Arnold, A.E.R. Bone, D.P. de Zwaan, C. de Erbel, R. Hillis, W.S. Lennane, R.J. Lubsen, J. Mathey, D. |
1987-01-01
|